R&D Systems Inc. Tocris Bioscience Boston Biochem

Tetrindole mesylate

Cat. No. 0723

Tetrindole mesylate C20H26N2.CH3SO3H [135991-95-6]

Price and Availability

For Tetrindole mesylate pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: 2,3,3a,4,5,6-Hexahydro-8-cyclohexyl­-1H-pyrazino[3,2,1-j,k]carbazole mesylate

Biological Activity

Novel antidepressant, a selective inhibitor of MAO-A.

Technical Data

M.Wt:
390.54
Formula:
C20H26N2.CH3SO3H
Solubility:
Soluble to 100 mM in DMSO
Purity:
>99 %
Storage:
Store at RT
CAS No:
135991-95-6

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Resources

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet

References

Medvedev et al (1994) Monoamine oxidase inhibition by novel antidepressant tetrindole. Biochem.Pharmacol. 47 303. PMID: 8304974.

Bos et al (1995) Resolution, EPC-syntheses, absolute stereochemistry, and pharmacology of the (S)-(+)- and (R)-(-)-isomers of the MAO-A inhibitor tetrindole hydrochloride. Arch.Pharm. (Wenheim) 328 619. PMID: 7492268.

Korshunov et al (2000) Hemodynamic effects of tetrindol in alert normotensive mice and rats after blockade of nitric oxide synthesis. Bull.Exp.Biol.Med. 130 777. PMID: 11177242.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

5-HT Receptors 5-HT3 Receptors 5-HT-Related Adrenergic Receptors Adrenergic Related Compounds
Dopamine Receptors Dopaminergic-Related Monoamine Oxidase Oxygenases/Oxidases

Keywords: Tetrindole mesylate, supplier, MAO-A, inhibitors, Monoamine, Oxygenases, Oxidases

Quick Order

Find multiple products by catalog number

divider line

Neurobiology of Parkinson's Disease

Written by A. Schapira

Parkinson's Poster

'Neurobiology and Therapeutics of Parkinson's Disease' highlights the neurobiology of Parkinson's disease and summarizes current and novel therapeutic interventions.

divider line

Antidepressants - Current and Future Targets

Written by P. Skolnich et al

Antidepressants poster

'Antidepressants - Current and Future Targets' provides an overview of the current and future targets for the treatment of major depressive disorder.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

New Products in this Area

NCX 466

Cyclooxygenase-inhibiting nitric oxide donor

Sign-up for new product e-alerts
divider line

Tocris Events

Win a Kindle

event

5th Conference on Advances in Molecular Mechanisms Underlying Neurological Disorders

June 23 - 26, 2013

Bath, UK